Brunelle Praschberger, Alicia
Post, Annemarie E. M.
Hermanns, Sanja
Graessner, Holm http://orcid.org/0000-0001-9803-7183
Funding for this research was provided by:
European Reference Network for Rare Neurological Diseases (Project ID No 739510)
Article History
Received: 13 October 2021
Accepted: 6 February 2022
First Online: 2 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: Holm Graessner receives/has received research support from the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF), the Bundesministerium für Gesundheit (BMG) and the European Union (EU). He has received consulting fees from Roche. He has received a speaker honorarium from Takeda.